Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Comfora - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Comfora

Approved

STANDARD

Comfora

Steril-Gene Life Sciences (P) Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: ea70a9a187112839
Company: Steril-Gene Life Sciences (P) Limited
Type: Standard

Approval Details

Approval Id: ea70a9a187112839
Drug Approval Philippines Name: Comfora
Product Name: Comfora
Registration Number: DR-XY48963
Brand Name: Comfora
Generic Name: Pentosan Polysulfate Sodium
Dosage Form: Hard Gelatin Capsule
Dosage Strength: 100 mg
Manufacturer: Steril-Gene Life Sciences (P) Limited
Importer: Ambica International Corporation.
Distributor: Ambica International Corporation.
Issuance Date: 27 December 2023
Expiry Date: 27 December 2028
Pharmacologic Category: Urinary Analgesic and Anesthetic
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

ea70a9a187112839

Type

Standard

Back to Philippines FDA Approvals